Literature DB >> 8115781

Residual tumor (R) classification and prognosis.

P Hermanek1, C Wittekind.   

Abstract

The tumor status following treatment is described by the residual tumor (R) classification: R0, no residual tumor; R1, microscopic residual tumor; R2, macroscopic residual tumor. Residual tumor may be found in the area of primary tumor and its regional lymph nodes and/or at distant sites. The R classification reflects the effects of treatment and influences further treatment planning. Furthermore, the R classification is a strong predictor of prognosis. An acceptable long-term prognosis can be expected only in R0 patients. Although there exist clear correlations between stage and R classification the differences in prognosis of R0 versus R1,2 cannot be explained by differences in stage alone. The prognostic significance of R classification is demonstrated by respective data for non-small cell lung carcinoma, squamous cell carcinoma of oesophagus, gastric carcinoma, ductal adenocarcinoma of the pancreas, colorectal carcinoma, lung and liver metastases.

Entities:  

Mesh:

Year:  1994        PMID: 8115781     DOI: 10.1002/ssu.2980100105

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  42 in total

1.  [Tumor classifications].

Authors:  C Wittekind; I Tischoff
Journal:  Pathologe       Date:  2004-11       Impact factor: 1.011

Review 2.  [R1 resection in the surgery of upper gastrointestinal tumors: relevance and therapeutic consequences].

Authors:  F Lordick; K Ott; A Novotny; C Schuhmacher; J R Siewert
Journal:  Chirurg       Date:  2007-09       Impact factor: 0.955

3.  [Residual cancer or not residual cancer--that is the question].

Authors:  P Meister
Journal:  Pathologe       Date:  2007-07       Impact factor: 1.011

4.  Right and Transverse Colonic Multi-Visceral Resections for Locally Advanced Cancers-a Single-Center Experience.

Authors:  Joseph Sebastian; Mohamed Boshnaq; Mohanraj Harilingam; Chukwuemeka Anele; Mansoor Akhtar; Deya Marzouk
Journal:  Indian J Surg Oncol       Date:  2018-04-20

5.  [Reduction of local recurrence and distant metastases in advanced rectal carcinoma by preoperative radiotherapy--results of a randomized study by the MRC (Medical Research Council)].

Authors:  R Fietkau
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

6.  PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer.

Authors:  Jingwu Li; Jianzhong Cui; Jinghua Zhang; Yuanting Liu; Longcai Han; Chunliang Jia; Jingyu Deng; Han Liang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 7.  Robotic Surgery for Malignant Liver Disease: a Systematic Review of Oncological and Surgical Outcomes.

Authors:  Rafael Diaz-Nieto; Soumil Vyas; Dinesh Sharma; Hassan Malik; Stephen Fenwick; Graeme Poston
Journal:  Indian J Surg Oncol       Date:  2019-06-13

Review 8.  Interventional Oncology Service Development.

Authors:  Samdeep Mouli; Jennifer C Baker; Daniel B Brown
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

9.  Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule.

Authors:  Eric Rullier; Christophe Laurent; Frédéric Bretagnol; Anne Rullier; Véronique Vendrely; Frank Zerbib
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

10.  N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy.

Authors:  Jingyu Deng; Rupeng Zhang; Yuan Pan; Baogui Wang; Liangliang Wu; Xishan Hao; Han Liang
Journal:  Tumour Biol       Date:  2013-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.